Jaydess®▼ (13.5mg intrauterine delivery system levonorgestrel) is an IUS indicated for contraception for up to 3 years.
Open-label extended trial involving 1453 women to evaluate efficacy, safety, tolerability of Kyleena for up to 5 years of use1
PP-PF-WHC-GB-1004 May 2022
Reporting adverse events and quality complaints
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.
If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: firstname.lastname@example.org
Further information is available on the “contact” tab at www.bayer.co.uk.